Astrana Health, Inc. (ASTH) – What Are Brokerages Saying About This Stock?

Shares of Astrana Health, Inc. (NASDAQ:ASTH) have earned an average rating of “Moderate Buy” from the ten analysts that are presently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $50.38.

Several research analysts have recently commented on ASTH shares. Wall Street Zen lowered Astrana Health from a “buy” rating to a “hold” rating in a research report on Sunday, August 16th. Barclays lifted their target price on shares of Astrana Health from $50.00 to $53.00 and gave the stock an “overweight” rating in a research report on Friday, August 7th. Needham & Company LLC lifted their price target on Astrana Health from $41.00 to $45.00 and gave the company a “buy” rating in a report on Friday. TD Cowen boosted their target price on shares of Astrana Health from $45.00 to $50.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Astrana Health in a research report on Thursday, August 27th.

Astrana Health Price Performance

Shares of NASDAQ ASTH opened at $34.50 on Monday. Astrana Health has a 1-year low of $18.08 and a 1-year high of $51.60. The stock has a fifty day simple moving average of $36.98 and a two-hundred day simple moving average of $34.02. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 1.05. The firm has a market cap of $1.92 billion, a price-to-earnings ratio of 32.24 and a beta of 1.18.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings data on Thursday, November 5th. The company reported $0.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.46 by $0.25. Astrana Health had a return on equity of 10.30% and a net margin of 1.05%. The business had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.02 billion. During the same quarter in the previous year, the business earned $0.01 earnings per share. The firm’s quarterly revenue was up 7.1% compared to the same quarter last year. Analysts anticipate that Astrana Health will post 1.36 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the stock. Maryland State Retirement & Pension System boosted its position in shares of Astrana Health by 50.7% during the third quarter. Maryland State Retirement & Pension System now owns 9,303 shares of the company’s stock valued at $331,000 after buying an additional 3,129 shares during the last quarter. Penn Capital Management Company LLC raised its stake in Astrana Health by 13.9% during the third quarter. Penn Capital Management Company LLC now owns 19,565 shares of the company’s stock valued at $696,000 after buying an additional 2,388 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al raised its stake in Astrana Health by 19.3% during the 3rd quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 13,600 shares of the company’s stock valued at $484,000 after buying an additional 2,200 shares during the last quarter. Simplicity Wealth LLC bought a new stake in shares of Astrana Health during the 3rd quarter valued at $296,000. Finally, Sterling Capital Management LLC raised its holdings in shares of Astrana Health by 17.2% during the 3rd quarter. Sterling Capital Management LLC now owns 9,269 shares of the company’s stock worth $330,000 after acquiring an additional 1,359 shares in the last quarter. Institutional investors own 52.77% of the company’s stock.

Key Headlines Impacting Astrana Health

Here are the key news stories impacting Astrana Health this week:

• Positive Sentiment: Needham raised its price target from $41 to $45 and reiterated a Buy rating, implying about 31% upside from the cited $34.38 share price. Needham rating information
• Positive Sentiment: Third-quarter revenue reached $1.02 billion, matching estimates and increasing 7.1% year over year; the company also reported a substantial improvement in earnings compared with the prior-year quarter. Astrana Health third-quarter results
• Negative Sentiment: Reports said Astrana’s quarterly revenue guidance fell short of expectations. That weaker forward outlook may have outweighed the revenue growth and profit improvement in the reported quarter, pressuring the shares. Report on results and guidance

Astrana Health Company Profile

Astrana Health, Inc (NASDAQ: ASTH), formerly known as Apollo Medical Holdings, is a healthcare enablement company focused on helping providers and health plans deliver coordinated, value-based care. The company combines physician networks, care-management capabilities, technology and data analytics to support improved clinical outcomes and more efficient healthcare delivery.

Astrana Health’s services include population health management, physician practice support, utilization management, care coordination and clinical analytics.